Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|July 9, 2018
Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15Heather J Adam, Alyssa R Golden, James A Karlowsky, et al.
The Journal of Antimicrobial Chemotherapy|July 9, 2018
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15James A Karlowsky, Heather J Adam, Alyssa R Golden, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 2011
Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007-2009 studyKimberly A Nichol, Heather J Adam, Zafar Hussain, et al.
Jac-Antimicrobial Resistance|February 14, 2022
Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007-19Alyssa R Golden, Melanie R Baxter, James A Karlowsky, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2013
Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 studyGeorge G Zhanel, Heather J Adam, Melanie R Baxter, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 2018
Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 studyAndrew J Denisuik, Lauren A Garbutt, Alyssa R Golden, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2013
Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007-11Philippe R S Lagacé-Wiens, Heather J Adam, Donald E Low, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16Philippe R S Lagacé-Wiens, Heather J Adam, Susan Poutanen, et al.
Drugs|November 28, 2020
Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial PneumoniaGeorge G Zhanel, Christina Deng, Sheryl Zelenitsky, et al.
Pageof 10